We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYACU
5401
DELISTED
Haymaker Acquisition Corp. II Unit
HYACU
$262K ﹤0.01%
24,921
-79
-0.3% -$825
VAL
5402
PUT
DELISTED
Valaris plc Class A Ordinary Share
VAL
$262K ﹤0.01%
40,000
MRSN
5403
DELISTED
Mersana Therapeutics
MRSN
$261K ﹤0.01%
1,819
+679
+60% +$49.6K
SPFI icon
5404
South Plains Financial
SPFI
$838M
$261K ﹤0.01%
12,496
+8,342
+201% +$151K
CFFI icon
5405
C&F Financial
CFFI
$277M
$260K ﹤0.01%
4,694
+1,544
+49% +$82.3K
ESQ icon
5406
Esquire Financial Holdings
ESQ
$1.12B
$260K ﹤0.01%
10,001
+1,854
+23% +$45.3K
SA
5407
Seabridge Gold
SA
$3.36B
$260K ﹤0.01%
18,800
+9,278
+97% +$117K
FNHC
5408
DELISTED
FedNat Holding Company Common Stock
FNHC
$260K ﹤0.01%
15,606
+6,530
+72% +$97.6K
SRACU
5409
DELISTED
Stable Road Acquisition Corp. Unit
SRACU
$260K ﹤0.01%
+25,300
New +$256K
PK icon
5410
PUT
Park Hotels & Resorts
PK
$2.92B
$259K ﹤0.01%
+10,000
New +$239K
SRRK icon
5411
Scholar Rock
SRRK
$6.32B
$259K ﹤0.01%
19,636
+4,545
+30% +$43.6K
STOK icon
5412
Stoke Therapeutics
STOK
$2.08B
$259K ﹤0.01%
9,149
+3,075
+51% +$77.3K
PARAA
5413
DELISTED
Paramount Global Class A
PARAA
$258K ﹤0.01%
5,745
+5,207
+968% +$221K
WOW
5414
DELISTED
WideOpenWest
WOW
$258K ﹤0.01%
34,886
+13,369
+62% +$84.7K
MPX
5415
DELISTED
Marine Products Corp
MPX
$257K ﹤0.01%
17,849
-53,665
-75% -$777K
MUH
5416
DELISTED
Blackrock Muniholdings Fund II, Inc.
MUH
$257K ﹤0.01%
16,876
-78,385
-82% -$1.17M
FPI
5417
Farmland Partners
FPI
$424M
$256K ﹤0.01%
37,686
+12,764
+51% +$84.1K
VLGEA icon
5418
Village Super Market
VLGEA
$616M
$256K ﹤0.01%
11,047
+3,818
+53% +$99K
ITI
5419
DELISTED
Iteris, Inc.
ITI
$256K ﹤0.01%
51,281
+18,971
+59% +$96.6K
GRTS
5420
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$256K ﹤0.01%
28,547
+8,244
+41% +$68.7K
ASXC
5421
DELISTED
Asensus Surgical, Inc.
ASXC
$256K ﹤0.01%
174,299
+15,468
+10% +$53.7K
STON
5422
DELISTED
StoneMor Inc.
STON
$256K ﹤0.01%
176,654
+46,102
+35% +$53.3K
ARGX icon
5423
argenx
ARGX
$54.2B
$255K ﹤0.01%
1,587
-1,230
-44% -$166K
RICK icon
5424
RCI Hospitality Holdings
RICK
$207M
$255K ﹤0.01%
12,437
+4,336
+54% +$83.6K
MSON
5425
DELISTED
Misonix Inc
MSON
$255K ﹤0.01%
13,703
+3,913
+40% +$71.6K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.